EP Patent

EP1789446A2 — Heteromultimeric molecules

Assigned to Genentech Inc · Expires 2007-05-30 · 19y expired

What this patent protects

The invention provides heteromultimeric antibodies, and methods of making these antibodies at high yields and purity. The invention also provides methods and compositions for using these antibodies.

USPTO Abstract

The invention provides heteromultimeric antibodies, and methods of making these antibodies at high yields and purity. The invention also provides methods and compositions for using these antibodies.

Drugs covered by this patent

Patent Metadata

Patent number
EP1789446A2
Jurisdiction
EP
Classification
—
Expires
2007-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.